49.3k views
2 votes
Dopamine is a neurotransmitter involved in the reward pathways in the brain, and its decreased activity has been associated with diseases such as Parkinson’s disease and attention-deficit/hyperactivity disorder (ADHD). Which of the following drugs is NOT a likely candidate to treat these diseases?

A. Methylphenidate, a dopamine reuptake inhibitor

B. Amphetamine, a dopamine-releasing agent that triggers the release of dopamine into the synaptic cleft

C. Carbidopa, which enhances the availability of the dopamine synthesis precursors in the brain

D. Forskolin, a sensitizer of dopamine receptors

E. Chlorpromazine, a dopamine antagonist that binds to and inhibits dopamine receptors

User Steven P
by
8.1k points

2 Answers

2 votes
The answer should be amphetamine a dopamine release agent that triggers the
User Artur Pyszczuk
by
7.6k points
5 votes

Answer:

The answer is E; Chlorpromazine, a dopamine antagonist that binds to and inhibits dopamine receptors

Step-by-step explanation:

Chlorpromazine which is a dopamine antagonist is not a candidate to treat Parkinson's disease and attention-deficit/hyperactivity disorder (ADHD) because as a dopamine antagonist it works by binding to dopamine receptors but does not activate it, thus blocking the actions of dopamine or exogenous agonists.

User JiiB
by
9.0k points
Welcome to QAmmunity.org, where you can ask questions and receive answers from other members of our community.

9.4m questions

12.2m answers

Categories